Established Formulation Screening Platform: Well established formulation screening platform specifically designed for the development of siRNA
High - concentration siRNA Formulation Expertise: Extensively experienced in formulating siRNA at high concentrations up to 200 mg/mL, ensuring controlled viscosity, osmolarity, and pH levels for enhanced product stability
Viscosity Control: Capable to achieve siRNA concentrations of up to 200 mg/mL while maintaining a viscosity below 6 cP, facilitating ease of handling and administration
Rigorous API Assessment: Thorough review of the API’s COA to ensure batch consistency and compliance with specifications, minimizing formulation variability
Optimized pH Titration and Dilution Processes: Ensuring batch consistency and quality control at every stage of formulation
Our specialized services in siRNA formulation are designed to deliver high-quality products that meet the rigorous demands of the pharmaceutical industry, ensuring reliable performance and regulatory compliance.